The IPO markets are headed into August on a slowing pace as there are only two offerings on the block this week. The largest is a materials company that was a spin-off and could go on record as the tenth largest deal of the year. The other is a bio tech company that is focused on rare bone diseases. While it is still a bit early, the IPO markets do tend to slow down in the coming weeks for summer break.
While the two deals will garner their own media attention, the real media focus will likely be on Snap, Inc. (NASDAQ: SNAP) as they hit their first lock-up expiration on Monday. There is a potential for an additional 400 million shares to be available to be traded as of this week.. Any volatility in the stock will likely be blamed on the lock-up.
Venator Materials (NYSE: VNTR) is the largest of the two offerings this week as they attempt to raise $477 million. The company is a leading manufacturer of titanium dioxide pigments and additives and is formerly a holding of the Huntsman Corporation (NYSE: HUN). Their financials have seen a boost recently as titanium dioxide pricing has sky rocketed. They will be offering 22.7 million shares to the public at a price range of $20 - $22.
Clementia Pharmaceuticals (NASDAQ: CMTA) is a clinical stage biotech company that is focusing its efforts on rare bone diseases. While they will offer 7.15 million shares to the public at a range of $13 - $15, they have a group of backers that have agreed to buy up $30 million of the deal. They are looking to raise $100 million in total.